We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Food and Drug Administration (FDA) is seeking comments on a proposed rule to amend the requirements for direct-to-consumer (DTC) advertisements as mandated under the Food and Drug Administration Amendments Act of 2007 (FDAAA
On June 22, 2009, the FDA announced a public comment opportunity on its "Experimental Study of Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer (DTC) Television and Print Advertisements for Prescription Drugs
On May 27, 2009, the Food and Drug Administration (FDA) published a notice soliciting comments on a draft guidance document entitled "Presenting Risk Information in Prescription Drug and Medical Device Promotion."
